Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human PSPN ELISA Kit (AC2862)
Cat.#: ASET-1451
Specifications
Description Human PSPN ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human PSPN concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 2.39 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 40-640 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1897 Mouse Estrogen Receptor beta ELISA Kit (AC3308) Quantitative inquiry ASET-1755 Human NK-2R ELISA Kit (AC3166) Quantitative inquiry ASET-2499 Human Galanin ELISA Kit (AC3910) Quantitative inquiry ASET-1831 Human SFRP1 ELISA Kit (AC3242) Quantitative inquiry ASET-1541 Mouse Notch1 ELISA Kit (AC2952) Quantitative inquiry ASET-1077 Human KCNAB2 ELISA Kit (AC2488) Quantitative inquiry ASET-2442 Human Ephrin B2 ELISA Kit (AC3853) Quantitative inquiry ASET-2506 Bovine Antidiuretic Hormone ELISA Kit (AC3917) Quantitative inquiry ASET-1685 Human Ephrin B1 ELISA Kit (AC3096) Quantitative inquiry ASET-2003 Mouse EDG8 ELISA Kit (AC3414) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket